Commercial leadership
Market development, account strategy, multi-state growth and commercialization planning.
About USHSG
Commercial strategy built for healthcare innovation and responsible adoption.
USHSG works with medical device, digital health and healthcare AI companies that need U.S. market strategy, independent specialist input and disciplined commercial testing connected in one engagement.
Our role
USHSG leads the commercial strategy and the engagement architecture.
We assess the market, define the commercialization work, coordinate the project and connect the client with independent clinical and industry specialists when their expertise is required.
USHSG does not claim to be the physician, scientist, reimbursement specialist, regulatory professional or technical specialist. Independent specialists retain responsibility for their own professional judgment, credentials and scope.
What clients should expect
Clear commercial objectives
Defined deliverables and responsibilities
Project-specific independent expertise
Written scopes and commercial terms
Measured market testing when appropriate
Markets we support
U.S. entry, U.S. expansion and broader commercial readiness.
USHSG supports international companies preparing to enter the United States and U.S. companies that need to expand across domestic markets or prepare for broader commercial and regulatory growth.
Formal legal opinions, regulatory submissions, certification decisions and other regulated professional services remain with the qualified party responsible for that work.
Focus areas
Neuromodulation & PainRehabilitation & MSKDigital HealthHealthcare AIMedical DevicesAdvanced Therapies
Founder & Principal
Dylan Gaar
Commercial leadership experience spans greenfield medical-device development, multi-state healthcare growth, neuromodulation, institutional market strategy and healthcare commercialization.
Engagement leadership
Client strategy, specialist coordination, pilot design and commercialization program management.